10-day sequential therapy was more effective than 10-day triple-drug therapy for eradicating Helicobacter pylori infection: COMMENTARY

Wong, Vincent Wai-Sun; Chan, Francis Ka-Leung
September 2007
ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p40
Academic Journal
The article presents the authors' views on a research that suggested higher success rate of sequential drug therapy for the eradication of Helicobacter pylori infection. The research found that quadruple therapy or levofloxacin-based triple therapy had 89% success rate compared with 77% of the standard triple therapy. It is stated that the research was conducted only on nine patients in Italy, a country known for its relatively lower rates of metronidazole and multi-drug resistance.


Related Articles

  • Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication.  // Annals of Internal Medicine;4/17/2007, Vol. 146 Issue 8, pI20 

    The article cites a study which investigates the effectiveness of a 4-drug sequential regimen compared to a standard 3-drug regimen in eradicating Helicobacter pylori (H. pylori). The researchers conducted the study on 300 adults with H. pylori infection and stomach pain or peptic ulcers who...

  • Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication. Vaira, Dino; Zullo, Angelo; Vakil, Nimish; Gatta, Luigi; Ricci, Chiara; Perna, Federico; Hassan, Cesare; Bernabucci, Veronica; Tampieri, Andrea; Morini, Sergio // Annals of Internal Medicine;4/17/2007, Vol. 146 Issue 8, p556 

    Background: Antimicrobial resistance has decreased eradication rates for Helicobacter pylori infection worldwide. Objective: To determine whether sequential treatment eradicates H. pylori infection better than standard triple-drug therapy for adults with dyspepsia or peptic ulcers. Design:...

  • Eradication therapies for H. pylori. WALLING, ANNE D. // American Family Physician;1/15/1999, Vol. 59 Issue 2, p470 

    Presents information on eradication therapies for Helicobacter pylori infections. Recommended regimens; Efficacy rates; Alternative therapies.

  • Drug Therapy for Helicobacter pylori Infection: Problems and Pitfalls. Glupczynski, Youri; Burette, Alain // American Journal of Gastroenterology;Dec1990, Vol. 85 Issue 12, p1545 

    Antibacterial chemotherapy against Helicobacter pylori is currently being assessed by open or randomized controlled clinical studies for its efficacy in eradicating this bacterium from the stomach of patients with gastritis or gastroduodenal ulcer. Whereas there is presently no...

  • Combination of Triple Therapy and Chronic PPI Use May Decrease Risk of Colonic Adenomatous Polyps in Helicobacter pylori Infection. Zuniga, Rina; Bautista, Josef; Sapra, Katherine; Westerfield, Keith; Williams, Susan; Sy, Alexander M. // Gastroenterology Research & Practice;5/12/2015, Vol. 2015, p1 

    Aim. The aim of the paper is to determine association between H. pylori and colonic adenomatous polyps and to explore whether treatment or chronic PPI use can mitigate this risk. Methods. This case-control study included 943 patients who had H. pylori testing and underwent colonoscopy. Presence...

  • Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication.  // Einstein (16794508);Apr2009, Vol. 7 Issue 2, p77 

    The article presents a reprint of an article related to the eradication of Helicobacter pylori (H. pylori), which appeared in the journal "Annals of Internal Medicine." It focuses on a study done to find whether sequential treatment is better than standard triple-drug therapy for the eradication...

  • In the wake of a positive H. Pylori serology. O'Connor, Patrick G. // Cortlandt Forum;08/25/98, Vol. 11 Issue 8, p96 

    Offers advice on the management of patients diagnosed with positive infection to Helicobacter pylori. Administration of antibiotic therapy after positive serologic results; Conduction of follow-up treatments to patients; Treatment requirements for symptomatic and asymptomatic patients.

  • H pylori: Low-dose Rx works just as well, reduces side effects.  // Modern Medicine;Jun94, Vol. 62 Issue 6, p55 

    Presents an abstract of the article `Use of high-efficacy, lower-dose triple therapy to reduce side effects of eradicating helicobacter pylori,' published in the American Journal of Gastroenterology and the `Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow-up'...

  • New ulcer drugs may simplify, improve treatment. Waldron, Theresa // Drug Topics;3/4/96, Vol. 140 Issue 5, p68 

    Focuses on the attempt of drug companies to seek approval from the US Food and Drug Administration to market simpler, combined therapies to treat helicobacter pylori, the bacteria that cause gastric and duodenal ulcers. Potential of combination antibiotic therapy as treatment for peptic ulcers;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics